- Home
- OR vs ALVO Comparison
OR vs ALVO Comparison
Compare OR & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OR
- ALVO
- Stock Information
- Founded
- OR 2014
- ALVO 2013
- Country
- OR Canada
- ALVO Luxembourg
- Employees
- OR N/A
- ALVO N/A
- Industry
- OR Precious Metals
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- OR Basic Materials
- ALVO Health Care
- Exchange
- OR Nasdaq
- ALVO Nasdaq
- Market Cap
- OR 3.1B
- ALVO 3.4B
- IPO Year
- OR N/A
- ALVO N/A
- Fundamental
- Price
- OR $18.25
- ALVO $11.91
- Analyst Decision
- OR Strong Buy
- ALVO Buy
- Analyst Count
- OR 1
- ALVO 1
- Target Price
- OR $22.00
- ALVO $18.00
- AVG Volume (30 Days)
- OR 518.0K
- ALVO 143.5K
- Earning Date
- OR 02-18-2025
- ALVO 11-13-2024
- Dividend Yield
- OR 1.05%
- ALVO N/A
- EPS Growth
- OR N/A
- ALVO N/A
- EPS
- OR N/A
- ALVO N/A
- Revenue
- OR $183,586,365.00
- ALVO $393,919,000.00
- Revenue This Year
- OR $5.16
- ALVO $398.12
- Revenue Next Year
- OR $30.26
- ALVO $44.73
- P/E Ratio
- OR N/A
- ALVO N/A
- Revenue Growth
- OR 1.62
- ALVO 517.92
- 52 Week Low
- OR $12.77
- ALVO $9.15
- 52 Week High
- OR $21.29
- ALVO $18.00
- Technical
- Relative Strength Index (RSI)
- OR 36.52
- ALVO 49.73
- Support Level
- OR $18.88
- ALVO $11.20
- Resistance Level
- OR $20.16
- ALVO $12.25
- Average True Range (ATR)
- OR 0.45
- ALVO 0.29
- MACD
- OR -0.13
- ALVO 0.08
- Stochastic Oscillator
- OR 4.00
- ALVO 67.62
About OR Osisko Gold Royalties Ltd
Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. The company organizes and manages the business under two operating segments: (i) acquiring and managing precious metals and other royalties, streams and other interests, and (ii) the exploration, evaluation and development of mining projects. Geographically, it generates majority of the income from North America and also generates some portions of income from South America, Australia, Africa and Europe.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.